Skip to Main Content

Paper Details

Dermatological Adverse Events in Prostate Cancer Patients Treated with the Androgen Receptor Inhibitor Apalutamide.
J Urol
8
2022
Author NameAffiliation
Sean M McBrideMemorial Sloan Kettering Cancer Center
Howard I ScherMemorial Sloan Kettering Cancer Center
Dana E RathkopfMemorial Sloan Kettering Cancer Center
  • 1 - 3

Datasets

Release 1.2